Clinical trials
Phase 2 Hemoglobin SC Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2004 | 1 |
| 2007 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 5 |
| Completed | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Baylor College of Medicine | 3 |
| Dana-Farber Cancer Institute | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Novartis Pharmaceuticals | 1 |
| Sangart | 1 |
| St. Jude Children's Research Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemoglobin SC Disease | 8 |
| Anemia, Sickle Cell | 5 |
| Vaso-Occlusive Crises | 3 |
| Hemoglobinopathies | 2 |
| Thalassemia | 2 |
| Acute Chest Syndrome | 1 |
| Graft vs Host Disease | 1 |
| beta-Thalassemia | 1 |
Trials
Showing 26 to 8 of 8. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.